health sciences
-
AstraZeneca Scientist Defends Plan to Start Selling COVID-19 Vaccine For Profit
A scientist who works on the AstraZeneca vaccine with Oxford University in the UK has come out to defend the decision to sell its COVID-19 vaccine at a profit, according to a new report from the Financial Times. AstraZeneca was previously unique because it sold the COVID-19 vaccine at cost, unlike most other vaccine makers…
-
Newly Approved Weight-Loss Drug Is Selling So Fast In The U.S. That Many People Can’t Get It
A recently FDA-approved weight loss drug heralded as “game-changing” by some researchers is selling like hotcakes. On Wednesday, Novo Nordisk announced an unexpectedly strong third quarter, fuelled by the release of its obesity drug Wegovy in the U.S. earlier this summer. The drug’s popularity has made it hard to get for some prospective patients, however,…
-
FDA Authorizes Pfizer Covid-19 Vaccine for Kids Age 5 to 11 in The U.S.
The U.S. Food and Drug Administration has now authorised the first covid-19 vaccine for children between the ages of 5 and 11. The authorization will cover the Pfizer/BioNTech mRNA vaccine, though the Centres for Disease Control and Prevention will have to give their blessing next week before the vaccine can be widely available.
-
A Cheap Antidepressant Can Keep Covid-19 Patients Out of the Hospital, Large Trial Finds
A cheap and widely available U.S. drug used as an antidepressant now also appears to be a lifesaving covid-19 treatment. In a newly published, large-scale clinical trial, the drug fluvoxamine was shown to reduce the risk of prolonged hospitalisation as well as death in high-risk patients treated at an emergency room. Coupled with the results…